跳至主要内容
临床试验/NCT01617720
NCT01617720已完成不适用

MITRAFIT Cardinal Adjustable Mitral Repair Follow-up International Postmarketing Surveillance (PMS)

Edwards Lifesciences2 个研究点 分布在 2 个国家目标入组 45 人开始时间: 2012年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
45
试验地点
2
主要终点
• Ability of the Cardinal ring to reduce mitral valve regurgitation

研究概览

简要总结

This Study is designed to observe the clinical outcomes of patients requiring mitral repair that were treated with the CE certified Cardinal System.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 years
  • Patient is a candidate for mitral valve repair, with our without concomitant procedures.
  • Subject is willing to give informed consent for collection of his/her clinical data.

排除标准

  • Severe organic lesions with retracted chordae
  • Congenital malformations with lack of valvular tissue
  • Severe valvular calcifications
  • Evolving bacterial endocarditis
  • Known Sensitivity to Nickel or Chromium

结局指标

主要结局

• Ability of the Cardinal ring to reduce mitral valve regurgitation

时间窗: 30 day

• Percentage of patients in whom the size of the ring is adjusted

时间窗: 6 months

• Technical feasibility of adjustment.

时间窗: 6 months

The ability of the surgeon to adjust the Cardinal ring when required, will be measured on a scale of 1-3 (1- successfull, 3- unsuccessful)

• The occurrence of serious device related adverse events in all patients.

时间窗: 6 months

次要结局

未报告次要终点

研究者

发起方
Edwards Lifesciences
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验